EnCompass Technologies

f2 embolic debri filtration device

Our Vision

To eliminate brain injury, including stroke, due to embolic debris during cardiac procedures.

Our Mission

To benefit patients by advancing effective, efficient, and safe embolic filtration across the spectrum of cardiac procedures.

Our Leadership


Press Release

May 23, 2023

World's First Use of EnCompass Medical Device to Protect Against Brain Injury Achieved at the Israeli-Georgian Medical Research Clinic, Tbilisi, Georgia

Read The Full Article


July 30, 2023

E-088 A novel neuroprotection device, EnCompass F2 for improved stroke prevention in transcatheter aortic valve replacement: an in vitro study

Read The Full Article

Press Release

EnCompass receives FDA conditional IDE approval to commence a US pilot study of its F2 cerebral embolic protection (CEP) system in patients undergoing transcatheter aortic valve replacement (TAVR)

Read The Full Article